{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:25:38Z","timestamp":1773307538646,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"publisher","award":["ISS20-80d80820cc41"],"award-info":[{"award-number":["ISS20-80d80820cc41"]}],"id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s43440-026-00838-6","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:18:54Z","timestamp":1770959934000},"page":"446-465","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic fasudil treatment induces benzodiazepine-like tolerance via modulation of GABA-A receptor \u03b32 subunit expression and impairs contextual fear memory in mice"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5250-8105","authenticated-orcid":false,"given":"Teresa","family":"Dipol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9955-2483","authenticated-orcid":false,"given":"Ornella","family":"Morsilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-7709","authenticated-orcid":false,"given":"Andrea","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1220-333X","authenticated-orcid":false,"given":"Valentina","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1664-2687","authenticated-orcid":false,"given":"Gianmauro","family":"Palombelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0659-3076","authenticated-orcid":false,"given":"Zaira","family":"Maroccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7480-5309","authenticated-orcid":false,"given":"Marcello","family":"Belfiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8978-0530","authenticated-orcid":false,"given":"Gabriele","family":"Campana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-2284","authenticated-orcid":false,"given":"Laura","family":"Ricceri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7070-9662","authenticated-orcid":false,"given":"Marco","family":"Feligioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6734-6979","authenticated-orcid":false,"given":"Caterina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8456-4169","authenticated-orcid":false,"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-9439","authenticated-orcid":false,"given":"Giacomo","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-4491","authenticated-orcid":false,"given":"Graziano","family":"Onder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1816-548X","authenticated-orcid":false,"given":"Ciro Leonardo","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9093-6803","authenticated-orcid":false,"given":"Rossella","family":"Canese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6344-2613","authenticated-orcid":false,"given":"Stefano","family":"Loizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"838_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3389\/fncel.2014.00314","volume":"8","author":"TR Stankiewicz","year":"2014","unstructured":"Stankiewicz TR, Linseman DA. Rho family gtpases: key players in neuronal development, neuronal survival, and neurodegeneration. Front Cell Neurosci. 2014;8:314. https:\/\/doi.org\/10.3389\/fncel.2014.00314.","journal-title":"Front Cell Neurosci"},{"key":"838_CR2","doi-asserted-by":"publisher","unstructured":"DeGeer J, Lamarche-Vane N. Rho GTPases in neurodegeneration diseases. Exp Cell Res. 2013;2384\u201394. https:\/\/doi.org\/10.1016\/j.yexcr.2013.06.016.","DOI":"10.1016\/j.yexcr.2013.06.016"},{"key":"838_CR3","doi-asserted-by":"publisher","unstructured":"Aguilar BJ, Zhu Y, Lu Q. Rho GTPases as therapeutic targets in alzheimer\u2019s disease. Alzheimer\u2019s Res Ther. 2017;97. https:\/\/doi.org\/10.1186\/s13195-017-0320-4.","DOI":"10.1186\/s13195-017-0320-4"},{"key":"838_CR4","doi-asserted-by":"publisher","first-page":"1481983","DOI":"10.3389\/fnins.2024.1481983","volume":"18","author":"Q Ye","year":"2024","unstructured":"Ye Q, Li X, Gao W, Gao J, Zheng L, Zhang M, Yang F, Li H. Role of Rho-associated kinases and their inhibitor fasudil in neurodegenerative diseases. Front Neurosci. 2024;18:1481983. https:\/\/doi.org\/10.3389\/fnins.2024.1481983.","journal-title":"Front Neurosci"},{"key":"838_CR5","doi-asserted-by":"publisher","first-page":"1547883","DOI":"10.3389\/fragi.2025.1547883","volume":"6","author":"C Zheng","year":"2025","unstructured":"Zheng C, Xia W, Zhang J. Rock inhibitors in alzheimer\u2019s disease. Front Aging. 2025;6:1547883. https:\/\/doi.org\/10.3389\/fragi.2025.1547883.","journal-title":"Front Aging"},{"key":"838_CR6","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/CELLS11091520","volume":"11","author":"SI Schmidt","year":"2022","unstructured":"Schmidt SI, Blaabjerg M, Freude K, Meyer M. RhoA signaling in neurodegenerative diseases. Cells. 2022;11:1520. https:\/\/doi.org\/10.3390\/CELLS11091520.","journal-title":"Cells"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"113481","DOI":"10.1016\/j.bbr.2021.113481","volume":"414","author":"RL Cai","year":"2021","unstructured":"Cai RL, Wang YY, Huang ZT, Zou Q, Pu YS, Yu C, et al. Role of RhoA\/ROCK signaling in alzheimer\u2019s disease. Behav Brain Res. 2021;414:113481. https:\/\/doi.org\/10.1016\/j.bbr.2021.113481.","journal-title":"Behav Brain Res"},{"key":"838_CR8","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/jnc.13688","volume":"138","author":"BW Henderson","year":"2016","unstructured":"Henderson BW, Gentry EG, Rush T, Troncoso JC, Thambisetty M, Montine TJ, et al. Rho-associated protein kinase 1 (ROCK1) is increased in alzheimer\u2019s disease and ROCK1 depletion reduces amyloid-\u03b2 levels in brain. J Neurochem. 2016;138:525\u201331. https:\/\/doi.org\/10.1111\/jnc.13688.","journal-title":"J Neurochem"},{"key":"838_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2176\/NMC.46.421","volume":"46","author":"J Zhao","year":"2006","unstructured":"Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, et al. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage: results of a randomized trial of fasudil hydrochloride versus nimodipine. Neurol Med Chir (Tokyo). 2006;46:421\u20137. https:\/\/doi.org\/10.2176\/NMC.46.421.","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"838_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0022-5347(25)00221-6","volume":"241","author":"T Asano","year":"1987","unstructured":"Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Takayasu M, et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther. 1987;241:1033\u201340.","journal-title":"J Pharmacol Exp Ther"},{"key":"838_CR11","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.4103\/1673-5374.335827","volume":"17","author":"Q Wang","year":"2022","unstructured":"Wang Q, Song LJ, Ding Z, Bin, Chai Z, Yu JZ, Xiao BG, et al. Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases. Neural Regen Res. 2022;17:2623\u201331. https:\/\/doi.org\/10.4103\/1673-5374.335827.","journal-title":"Neural Regen Res"},{"key":"838_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-2010-091114","volume":"20","author":"BA Couch","year":"2010","unstructured":"Couch BA, Demarco GJ, Gourley SL, Koleske AJ. Increased dendrite branching in A\u03b2PP\/PS1 mice and elongation of dendrite arbors by fasudil administration. J Alzheimer\u2019s Dis. 2010;20:1003\u20138. https:\/\/doi.org\/10.3233\/JAD-2010-091114.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"838_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.5114\/FN.2021.105130","volume":"59","author":"W Wei","year":"2021","unstructured":"Wei W, Wang Y, Zhang J, Gu Q, Liu X, Song L, et al. Fasudil ameliorates cognitive deficits, oxidative stressand neuronal apoptosis via inhibiting ROCK\/MAPKand activating Nrf2 signalling pathways in APP\/PS1 mice. Folia Neuropathol. 2021;59:32\u201349. https:\/\/doi.org\/10.5114\/FN.2021.105130.","journal-title":"Folia Neuropathol"},{"key":"838_CR14","unstructured":"Study Details. Fasudil trial for treatment of early Alzheimer\u2019s disease (FEAD). ClinicalTrials.gov. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05931575?cond=parkinson&term=fasudil&rank=1."},{"key":"838_CR15","unstructured":"Study Details. Safety. Tolerability and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson\u2019s disease. ClinicalTrials.gov. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05931575?cond=parkinson&term=fasudil&rank=1"},{"key":"838_CR16","unstructured":"Study Details. Rho kinase inhibitor in amyotrophic lateral sclerosis (REAL). ClinicalTrials.gov. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05218668?cond=AmyotrophicLateral%20Sclerosis&term=fasudil&rank%E2%80%89=%E2%80%891."},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/J.EJPHAR.2017.01.021","volume":"797","author":"L Huang","year":"2017","unstructured":"Huang L, Li Q, Wen R, Yu Z, Li N, Ma L, et al. Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats. Eur J Pharmacol. 2017;797:134\u201342. https:\/\/doi.org\/10.1016\/J.EJPHAR.2017.01.021.","journal-title":"Eur J Pharmacol"},{"key":"838_CR18","doi-asserted-by":"publisher","first-page":"e14209","DOI":"10.1111\/ACEL.14209","volume":"23","author":"Z Wang","year":"2024","unstructured":"Wang Z, Dong J, Zhang M, Wang S, Wu J, Wang S, et al. Sevoflurane-induced overexpression of extrasynaptic \u03b15-GABAAR via the RhoA\/ROCK2 pathway impairs cognitive function in aged mice. Aging Cell. 2024;23:e14209. https:\/\/doi.org\/10.1111\/ACEL.14209.","journal-title":"Aging Cell"},{"key":"838_CR19","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/J.NBD.2018.12.015","volume":"124","author":"LP Shapiro","year":"2019","unstructured":"Shapiro LP, Kietzman HW, Guo J, Rainnie DG, Gourley SL. Rho-kinase Inhibition has antidepressant-like efficacy and expedites dendritic spine pruning in adolescent mice. Neurobiol Dis. 2019;124:520\u201330. https:\/\/doi.org\/10.1016\/J.NBD.2018.12.015.","journal-title":"Neurobiol Dis"},{"key":"838_CR20","doi-asserted-by":"publisher","first-page":"100234","DOI":"10.1016\/j.ynstr.2020.100234","volume":"13","author":"L Rom\u00e1n-Albasini","year":"2020","unstructured":"Rom\u00e1n-Albasini L, D\u00edaz-V\u00e9liz G, Olave FA, Aguayo FI, Garc\u00eda-Rojo G, Corrales WA, et al. Antidepressant-relevant behavioral and synaptic molecular effects of long-term fasudil treatment in chronically stressed male rats. Neurobiol Stress. 2020;13:100234. https:\/\/doi.org\/10.1016\/j.ynstr.2020.100234.","journal-title":"Neurobiol Stress"},{"key":"838_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/IJNP\/PYW108","volume":"20","author":"G Garc\u00eda-Rojo","year":"2017","unstructured":"Garc\u00eda-Rojo G, Fresno C, Vilches N, D\u00edaz-V\u00e9liz G, Mora S, Aguayo F, et al. The ROCK inhibitor fasudil prevents chronic restraint stress-induced depressive-like behaviors and dendritic spine loss in rat hippocampus. Int J Neuropsychopharmacol. 2017;20:336\u201345. https:\/\/doi.org\/10.1093\/IJNP\/PYW108.","journal-title":"Int J Neuropsychopharmacol"},{"key":"838_CR22","unstructured":"Costa E, Guidotti A, Mao CC. Evidence for involvement of GABA in the action of benzodiazepines: studies on rat cerebellum. Adv Biochem Psychopharmacol. 1975;113\u201330."},{"key":"838_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/BJP.2008.225","volume":"155","author":"SY Inan","year":"2008","unstructured":"Inan SY, B\u00fcy\u00fckaf\u015far K. Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice. Br J Pharmacol. 2008;155:44\u201351. https:\/\/doi.org\/10.1038\/BJP.2008.225.","journal-title":"Br J Pharmacol"},{"key":"838_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S11940-016-0401-X","volume":"18","author":"JG Ochoa","year":"2016","unstructured":"Ochoa JG, Kilgo WA. The role of benzodiazepines in the treatment of epilepsy. Curr Treat Options Neurol. 2016;18:1\u201311. https:\/\/doi.org\/10.1007\/S11940-016-0401-X.","journal-title":"Curr Treat Options Neurol"},{"key":"838_CR25","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0074-7742(08)60663-7","volume":"39","author":"EM Barnes Jr","year":"1996","unstructured":"Barnes EM Jr. Use-dependent regulation of GABAA receptors. Int Rev Neurobiol. 1996;39:53\u201376. https:\/\/doi.org\/10.1016\/s0074-7742(08)60663-7.","journal-title":"Int Rev Neurobiol"},{"key":"838_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ejphar.2003.10.007","volume":"482","author":"J Voss","year":"2003","unstructured":"Voss J, Sanchez C, Michelsen S, Ebert B. Rotarod studies in the rat of the GABAA receptor agonist gaboxadol: lack of ethanol potentiation and benzodiazepine cross-tolerance. Eur J Pharmacol. 2003;482:215\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2003.10.007.","journal-title":"Eur J Pharmacol"},{"key":"838_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0149-7634(01)00011-2","volume":"25","author":"E Choleris","year":"2001","unstructured":"Choleris E, Thomas AW, Kavaliers M, Prato FS. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev. 2001;25:235\u201360. https:\/\/doi.org\/10.1016\/S0149-7634(01)00011-2.","journal-title":"Neurosci Biobehav Rev"},{"key":"838_CR28","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vascn.2006.04.001","volume":"54","author":"V Bertaina-Anglade","year":"2006","unstructured":"Bertaina-Anglade V, Enjuanes E, Morillon D, Drieu la Rochelle C. The object recognition task in rats and mice: A simple and rapid model in safety Pharmacology to detect amnesic properties of a new chemical entity. J Pharmacol Toxicol Methods. 2006;54:99\u2013105. https:\/\/doi.org\/10.1016\/j.vascn.2006.04.001.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"838_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.brat.2014.02.004","volume":"56","author":"G Hart","year":"2014","unstructured":"Hart G, Panayi MC, Harris JA, Westbrook RF. Benzodiazepine treatment can impair or spare extinction, depending on when it is given. Behav Res Ther. 2014;56:22\u20139. https:\/\/doi.org\/10.1016\/j.brat.2014.02.004.","journal-title":"Behav Res Ther"},{"key":"838_CR30","first-page":"423","volume":"5","author":"C Scheau","year":"2012","unstructured":"Scheau C, Preda EM, Popa GA, Ghergus AE, Capsa RA, Lupescu IG. Magnetic resonance Spectroscopy \u2013 a non-invasive method in evaluating focal and diffuse central nervous system disease. J Med Life. 2012;5:423.","journal-title":"J Med Life"},{"key":"838_CR31","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/j.bbapap.2010.04.008","volume":"1804","author":"CL Pierri","year":"2010","unstructured":"Pierri CL, Parisi G, Porcelli V. Computational approaches for protein function prediction: A combined strategy from multiple sequence alignment to molecular docking-based virtual screening. Biochim Biophys Acta - Proteins Proteom. 2010;1804:1695\u2013712. https:\/\/doi.org\/10.1016\/j.bbapap.2010.04.008.","journal-title":"Biochim Biophys Acta - Proteins Proteom"},{"key":"838_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/S41586-018-0255-3","volume":"559","author":"S Zhu","year":"2018","unstructured":"Zhu S, Noviello CM, Teng J, Walsh RM, Kim JJ, Hibbs RE. Structure of a human synaptic GABAA receptor. Nature. 2018;559:67\u201388. https:\/\/doi.org\/10.1038\/S41586-018-0255-3.","journal-title":"Nature"},{"key":"838_CR33","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.1038\/s41467-022-32212-4","volume":"13","author":"S Zhu","year":"2022","unstructured":"Zhu S, Sridhar A, Teng J, et al. Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities. Nat Commun. 2022;13:4582. https:\/\/doi.org\/10.1038\/s41467-022-32212-4.","journal-title":"Nat Commun"},{"key":"838_CR34","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0140-6736(81)90251-8","volume":"318","author":"A Darragh","year":"1981","unstructured":"Darragh A, Scully M, Lambe R, Brick I, O\u2019Boyle C, Downie WW, INVESTIGATION IN MAN OF THE EFFICACY OF A BENZODIAZEPINE ANTAGONIST. Ro 15-1788. Lancet. 1981;318:8\u201310. https:\/\/doi.org\/10.1016\/S0140-6736(81)90251-8.","journal-title":"Lancet"},{"key":"838_CR35","first-page":"47","volume":"38","author":"H M\u00f6hler","year":"1983","unstructured":"M\u00f6hler H. Benzodiazepine receptors: differential ligand interactions and purification of the receptor protein. Adv Biochem Psychopharmacol. 1983;38:47\u201356.","journal-title":"Adv Biochem Psychopharmacol"},{"key":"838_CR36","unstructured":"Fasudil. C14H17N3O2S. CID 3547 - PubChem. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Fasudil"},{"key":"838_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bcp.2015.11.019","volume":"100","author":"S Todisco","year":"2015","unstructured":"Todisco S, Di Noia MA, Onofrio A, Parisi G, Punzi G, Redavid G, et al. Identification of new highly selective inhibitors of the human ADP\/ATP carriers by molecular Docking and in vitro transport assays. Biochem Pharmacol. 2015;100:112\u201332. https:\/\/doi.org\/10.1016\/j.bcp.2015.11.019.","journal-title":"Biochem Pharmacol"},{"key":"838_CR38","doi-asserted-by":"publisher","first-page":"e51981","DOI":"10.15252\/EMBR.202051981","volume":"22","author":"A Menga","year":"2021","unstructured":"Menga A, Favia M, Spera I, Vegliante MC, Gissi R, De Grassi A, et al. N -acetylaspartate release by glutaminolytic ovarian cancer cells sustains protumoral macrophages. EMBO Rep. 2021;22:e51981. https:\/\/doi.org\/10.15252\/EMBR.202051981.","journal-title":"EMBO Rep"},{"key":"838_CR39","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/NPROT.2016.051","volume":"11","author":"S Forli","year":"2016","unstructured":"Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand Docking and virtual drug screening with the AutoDock suite. Nat Protoc. 2016;11:905\u201319. https:\/\/doi.org\/10.1038\/NPROT.2016.051.","journal-title":"Nat Protoc"},{"key":"838_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-111-6_2","volume-title":"Neuromethods","author":"S Spijker","year":"2011","unstructured":"Spijker S. Dissection of rodent brain regions. In: Springer N, Li KW, editors. Neuromethods. Totowa, NJ: Humana; 2011. https:\/\/doi.org\/10.1007\/978-1-61779-111-6_2."},{"key":"838_CR41","doi-asserted-by":"publisher","first-page":"13257","DOI":"10.1038\/srep13257","volume":"5","author":"S Macr\u00ec","year":"2015","unstructured":"Macr\u00ec S, Ceci C, Onori P. Mice repeatedly exposed to Group-A \u03b2-Haemolytic Streptococcus show perseverative behaviors, impaired sensorimotor gating and immune activation in rostral diencephalon. Sci Rep. 2015;5:13257. https:\/\/doi.org\/10.1038\/srep13257.","journal-title":"Sci Rep"},{"key":"838_CR42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41398-017-0076-4","volume":"8","author":"C Scuderi","year":"2018","unstructured":"Scuderi C, Bronzuoli MR, Facchinetti R, et al. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple Transgenic mouse model of alzheimer\u2019s disease by exerting anti-inflammatory and neuroprotective effects. Transl Psychiatry. 2018;8:32. https:\/\/doi.org\/10.1038\/s41398-017-0076-4.","journal-title":"Transl Psychiatry"},{"key":"838_CR43","doi-asserted-by":"publisher","first-page":"890855","DOI":"10.3389\/fnagi.2022.890855","volume":"14","author":"F Bellanti","year":"2022","unstructured":"Bellanti F, Bukke VN, Moola A, Villani R, Scuderi C, Steardo L, Palombelli G, Canese R, Beggiato S, Altamura M, Vendemiale G, Serviddio G, Cassano T. Effects of ultramicronized palmitoylethanolamide on mitochondrial Bioenergetics, cerebral Metabolism, and glutamatergic transmission: an integrated approach in a triple Transgenic mouse model of alzheimer\u2019s disease. Front Aging Neurosci. 2022;14:890855. https:\/\/doi.org\/10.3389\/fnagi.2022.890855.","journal-title":"Front Aging Neurosci"},{"key":"838_CR44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1006\/gyno.1993.1167","volume":"50","author":"DM Provencher","year":"1993","unstructured":"Provencher DM, Finstad CL, Saigo PE, Rubin SC, Hoskins WJ, Federici MG, et al. Comparison of antigen expression on fresh and cultured Ascites cells and on solid tumors of patients with epithelial ovarian cancer. Gynecol Oncol. 1993;50:78\u201383. https:\/\/doi.org\/10.1006\/gyno.1993.1167.","journal-title":"Gynecol Oncol"},{"key":"838_CR45","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/NBM.1779","volume":"25","author":"R Canese","year":"2012","unstructured":"Canese R, Pisanu ME, Mezzanzanica D, Ricci A, Paris L, Bagnoli M, et al. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging. NMR Biomed. 2012;25:632\u201342. https:\/\/doi.org\/10.1002\/NBM.1779.","journal-title":"NMR Biomed"},{"key":"838_CR46","doi-asserted-by":"publisher","first-page":"599204","DOI":"10.3389\/FONC.2020.599204\/XML\/NLM","volume":"10","author":"MF Penet","year":"2021","unstructured":"Penet MF, Kakkad S, Wildes F, Bhujwalla ZM. Water and collagen content are high in pancreatic cancer: implications for quantitative metabolic imaging. Front Oncol. 2021;10:599204. https:\/\/doi.org\/10.3389\/FONC.2020.599204\/XML\/NLM.","journal-title":"Front Oncol"},{"key":"838_CR47","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang X, Li Z, Gao X, Wu X, Pi J, et al. Melatonin attenuates brain edema via the PI3K\/Akt\/Nrf2 pathway in rats with cerebral ischemia-reperfusion injury. J Stroke Cerebrovasc Dis. 2025;34. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2025.108299.","DOI":"10.1016\/j.jstrokecerebrovasdis.2025.108299"},{"issue":"6","key":"838_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10822-012-9570-1","volume":"26","author":"CR Corbeil","year":"2012","unstructured":"Corbeil CR, Williams CI, Labute P. Variability in Docking success rates due to dataset Preparation. J Comput Aided Mol Des. 2012;26(6):775\u201386. https:\/\/doi.org\/10.1007\/s10822-012-9570-1.","journal-title":"J Comput Aided Mol Des"},{"issue":"20","key":"838_CR49","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.1021\/jm050362n","volume":"49","author":"GL Warren","year":"2006","unstructured":"Warren GL, Andrews CW, Capelli AM, Clarke B, LaLonde J, Lambert MH, Lindvall M, Nevins N, Semus SF, Senger S, Tedesco G, Wall ID, Woolven JM, Peishoff CE, Head MS. A critical assessment of Docking programs and scoring functions. J Med Chem. 2006;49(20):5912\u201331. https:\/\/doi.org\/10.1021\/jm050362n.","journal-title":"J Med Chem"},{"key":"838_CR50","unstructured":"Flumazenil. C15H14FN3O3. CID 3373 - PubChem. Available from: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Flumazenil"},{"key":"838_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbr.2018.05.024","volume":"351","author":"M Kumar","year":"2018","unstructured":"Kumar M, Bansal N. Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced alzheimer\u2019s disease: involvement of PI3-kinase, eNOS and NF\u03baB. Behav Brain Res. 2018;351:4\u201316. https:\/\/doi.org\/10.1016\/j.bbr.2018.05.024.","journal-title":"Behav Brain Res"},{"key":"838_CR52","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1097\/NEN.0000000000000095","volume":"73","author":"L Tatenhorst","year":"2014","unstructured":"Tatenhorst L, T\u00f6nges L, Saal KA, Koch JC, Szego \u00c9M, B\u00e4hr M, et al. Rho kinase Inhibition by fasudil in the striatal 6-hydroxydopamine lesion mouse model of Parkinson disease. J Neuropathol Exp Neurol. 2014;73:770\u20139. https:\/\/doi.org\/10.1097\/NEN.0000000000000095.","journal-title":"J Neuropathol Exp Neurol"},{"key":"838_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0278-5846(89)90024-9","volume":"13","author":"B S\u00f6derpalm","year":"1989","unstructured":"S\u00f6derpalm B, Eriksson E, Engel JA. Anticonflict and Rotarod impairing effects of Alprazolam and diazepam in rat after acute and subchronic administration. Prog Neuropsychopharmacol Biol Psychiatry. 1989;13:269\u201383. https:\/\/doi.org\/10.1016\/0278-5846(89)90024-9.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"838_CR54","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S0022-3565(25)20998-3","volume":"246","author":"LG Miller","year":"1988","unstructured":"Miller LG, Greenblatt DJ, Barnhill JG, Shader RI. Chronic benzodiazepine administration. I. Tolerance is associated with benzodiazepine receptor downregulation and decreased \u03b3-aminobutyric acid(A) receptor function. J Pharmacol Exp Ther. 1988;246:170\u20136.","journal-title":"J Pharmacol Exp Ther"},{"key":"838_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s12640-016-9688-3","volume":"31","author":"S Talarek","year":"2017","unstructured":"Talarek S, Listos J, Orzelska-Gorka J, Jakobczuk M, Kotlinska J, Biala G. The importance of l-Arginine:NO:cGMP pathway in tolerance to flunitrazepam in mice. Neurotox Res. 2017;31:309\u201316. https:\/\/doi.org\/10.1007\/s12640-016-9688-3.","journal-title":"Neurotox Res"},{"key":"838_CR56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2015.09.038","volume":"310","author":"MC Ferreri","year":"2015","unstructured":"Ferreri MC, Guti\u00e9rrez ML, Gravielle MC. Tolerance to the sedative and anxiolytic effects of diazepam is associated with different alterations of GABAA receptors in rat cerebral cortex. Neuroscience. 2015;310:152\u201362. https:\/\/doi.org\/10.1016\/j.neuroscience.2015.09.038.","journal-title":"Neuroscience"},{"key":"838_CR57","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/S41398-021-01718-8","volume":"11","author":"L Carton","year":"2021","unstructured":"Carton L, Niot C, Kyheng M, Petrault M, Laloux C, Potey C, et al. Lack of direct involvement of a diazepam long-term treatment in the occurrence of irreversible cognitive impairment: a pre-clinical approach. Transl Psychiatry. 2021;11:612. https:\/\/doi.org\/10.1038\/S41398-021-01718-8.","journal-title":"Transl Psychiatry"},{"key":"838_CR58","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.biopsych.2005.11.027","volume":"60","author":"C Grillon","year":"2006","unstructured":"Grillon C, Baas JMP, Pine DS, Lissek S, Lawley M, Ellis V, et al. The benzodiazepine Alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol Psychiatry. 2006;60:760\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2005.11.027.","journal-title":"Biol Psychiatry"},{"key":"838_CR59","doi-asserted-by":"publisher","first-page":"107504","DOI":"10.1016\/j.nlm.2021.107504","volume":"184","author":"KA Cummings","year":"2021","unstructured":"Cummings KA, Lacagnina AF, Clem RL. GABAergic microcircuitry of fear memory encoding. Neurobiol Learn Mem. 2021;184:107504. https:\/\/doi.org\/10.1016\/j.nlm.2021.107504.","journal-title":"Neurobiol Learn Mem"},{"key":"838_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.tins.2014.05.004","volume":"37","author":"MR Gilmartin","year":"2014","unstructured":"Gilmartin MR, Balderston NL, Helmstetter FJ. Prefrontal cortical regulation of fear learning. Trends Neurosci. 2014;37:455\u201364. https:\/\/doi.org\/10.1016\/j.tins.2014.05.004.","journal-title":"Trends Neurosci"},{"key":"838_CR61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2015.12.048","volume":"613","author":"Y Curto","year":"2016","unstructured":"Curto Y, Garcia-Mompo C, Bueno-Fernandez C, Nacher J. Chronic benzodiazepine treatment decreases spine density in cortical pyramidal neurons. Neurosci Lett. 2016;613:41\u20136. https:\/\/doi.org\/10.1016\/j.neulet.2015.12.048.","journal-title":"Neurosci Lett"},{"key":"838_CR62","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0026-895X(25)10150-8","volume":"45","author":"TJ Zhao","year":"1994","unstructured":"Zhao TJ, Chiu TH, Rosenberg HC. Reduced expression of gamma-aminobutyric acid type A\/benzodiazepine receptor gamma 2 and alpha 5 subunit mRNAs in brain regions of flurazepam-treated rats. Mol Pharmacol. 1994;45:657\u201363. https:\/\/doi.org\/10.1016\/S0026-895X(25)10150-8.","journal-title":"Mol Pharmacol"},{"key":"838_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/IJMS21124445","volume":"21","author":"JS Barker","year":"2020","unstructured":"Barker JS, Hines RM. Regulation of Gabaa receptor subunit expression in substance use disorders. Int J Mol Sci. 2020;21:1\u201322. https:\/\/doi.org\/10.3390\/IJMS21124445.","journal-title":"Int J Mol Sci"},{"key":"838_CR64","doi-asserted-by":"publisher","first-page":"416864","DOI":"10.1155\/2012\/416864","volume":"2012","author":"CH Vinkers","year":"2012","unstructured":"Vinkers CH, Olivier B. Mechanisms underlying tolerance after Long-Term benzodiazepine use: A future for Subtype-Selective GABAA receptor modulators? Adv Pharmacol Pharm Sci. 2012;2012:416864. https:\/\/doi.org\/10.1155\/2012\/416864.","journal-title":"Adv Pharmacol Pharm Sci"},{"key":"838_CR65","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/NRN1517","volume":"5","author":"E Kim","year":"2004","unstructured":"Kim E, Sheng M. PDZ domain proteins of synapses. Nat Rev Neurosci. 2004;5:771\u201381. https:\/\/doi.org\/10.1038\/NRN1517.","journal-title":"Nat Rev Neurosci"},{"key":"838_CR66","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1523\/JNEUROSCI.1711-10.2010","volume":"30","author":"D Oh","year":"2010","unstructured":"Oh D, Han S, Seo J, Lee JR, Choi J, Groffen J, et al. Regulation of synaptic Rac1 activity, long-term potentiation maintenance, and learning and memory by BCR and ABR Rac GTPase-activating proteins. J Neurosci. 2010;30:14134\u201344. https:\/\/doi.org\/10.1523\/JNEUROSCI.1711-10.2010.","journal-title":"J Neurosci"},{"key":"838_CR67","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/NN.2487","volume":"13","author":"A Hayashi-Takagi","year":"2010","unstructured":"Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat Neurosci. 2010;13:327\u201332. https:\/\/doi.org\/10.1038\/NN.2487.","journal-title":"Nat Neurosci"},{"key":"838_CR68","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/MP.2014.161","volume":"20","author":"PJ Fitzgerald","year":"2015","unstructured":"Fitzgerald PJ, Pinard CR, Camp MC, Feyder M, Sah A, Bergstrom HC, et al. Durable fear memories require PSD-95. Mol Psychiatry. 2015;20:901\u201312. https:\/\/doi.org\/10.1038\/MP.2014.161.","journal-title":"Mol Psychiatry"},{"key":"838_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10339-011-0430-z","volume":"13","author":"M Antunes","year":"2012","unstructured":"Antunes M, Biala G. The novel object recognition memory: neurobiology, test procedure, and its modifications. Cogn Process. 2012;13:93\u2013110. https:\/\/doi.org\/10.1007\/s10339-011-0430-z.","journal-title":"Cogn Process"},{"key":"838_CR70","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S0893-133X(01)00388-8","volume":"26","author":"P Brambilla","year":"2002","unstructured":"Brambilla P, Stanley JA, Nicoletti M, Harenski K, Wells KF, Mallinger AG, et al. 1H MRS brain measures and acute lorazepam administration in healthy human subjects. Neuropsychopharmacology. 2002;26:546\u201351. https:\/\/doi.org\/10.1016\/S0893-133X(01)00388-8.","journal-title":"Neuropsychopharmacology"},{"key":"838_CR71","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/0006-3223(92)90077-d","volume":"32","author":"RF Deicken","year":"1992","unstructured":"Deicken RF, Calabrese G, Raz J, Sappey-Marinier D, Meyerhoff D, Dillon WP, et al. A 31phosphorous magnetic resonance spectroscopy study of diazepam does not affect brain phosphorous metabolism. Biol Psychiatry. 1992;32:628\u201331. https:\/\/doi.org\/10.1016\/0006-3223(92)90077-d.","journal-title":"Biol Psychiatry"},{"key":"838_CR72","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s11064-018-2521-z","volume":"44","author":"JMN Duarte","year":"2019","unstructured":"Duarte JMN, Xin L. Magnetic resonance spectroscopy in schizophrenia: evidence for glutamatergic dysfunction and impaired energy metabolism. Neurochem Res. 2019;44:102\u201316.","journal-title":"Neurochem Res"},{"key":"838_CR73","doi-asserted-by":"publisher","first-page":"136410","DOI":"10.1016\/J.NEULET.2021.136410","volume":"770","author":"J Smucny","year":"2022","unstructured":"Smucny J, Carter CS, Maddock RJ. Magnetic resonance spectroscopic evidence of increased choline in the dorsolateral prefrontal and visual cortices in recent onset schizophrenia. Neurosci Lett. 2022;770:136410. https:\/\/doi.org\/10.1016\/J.NEULET.2021.136410.","journal-title":"Neurosci Lett"},{"issue":"12","key":"838_CR74","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/nbm.3045","volume":"26","author":"S Ramadan","year":"2013","unstructured":"Ramadan S, Lin A, Stanwell P. Glutamate and glutamine: a review of in vivo MRS in the human brain. NMR Biomed. 2013;26(12):1630\u201346. https:\/\/doi.org\/10.1002\/nbm.3045.","journal-title":"NMR Biomed"},{"key":"838_CR75","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.pscychresns.2017.11.009","volume":"271","author":"CA Riley","year":"2018","unstructured":"Riley CA, Renshaw PF. Brain choline in major depression: A review of the literature. Psychiatry Res Neuroimaging. 2018;271:142\u201353. https:\/\/doi.org\/10.1016\/j.pscychresns.2017.11.009. Epub 2017 Nov 20. PMID: 29174766.","journal-title":"Psychiatry Res Neuroimaging"},{"key":"838_CR76","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1148\/RADIOLOGY.201.3.8939209","volume":"201","author":"C Pierpaoli","year":"1996","unstructured":"Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology. 1996;201:637\u201348. https:\/\/doi.org\/10.1148\/RADIOLOGY.201.3.8939209.","journal-title":"Radiology"},{"key":"838_CR77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1503\/JPN.110059","volume":"37","author":"C Lochner","year":"2012","unstructured":"Lochner C, Fouch\u00e9 JP, du Plessis S, Spottiswoode B, Seedat S, Fineberg N, et al. Evidence for fractional anisotropy and mean diffusivity white matter abnormalities in the internal capsule and cingulum in patients with obsessive-compulsive disorder. J Psychiatry Neurosci. 2012;37:193\u20139. https:\/\/doi.org\/10.1503\/JPN.110059.","journal-title":"J Psychiatry Neurosci"},{"issue":"11","key":"838_CR78","doi-asserted-by":"publisher","first-page":"e1528","DOI":"10.1212\/WNL.0000000000010231","volume":"95","author":"LGM Cremers","year":"2020","unstructured":"Cremers LGM, Wolters FJ, de Groot M, Ikram MK, van der Lugt A, Niessen WJ, Vernooij MW, Ikram MA. Structural disconnectivity and the risk of dementia in the general population. Neurology. 2020;95(11):e1528\u201337. https:\/\/doi.org\/10.1212\/WNL.0000000000010231.","journal-title":"Neurology"},{"key":"838_CR79","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.jpsychires.2011.01.006","volume":"45","author":"KA Clark","year":"2011","unstructured":"Clark KA, Nuechterlein KH, Asarnow RF, Hamilton LS, Phillips OR, Hageman NS, et al. Mean diffusivity and fractional anisotropy as indicators of disease and genetic liability to schizophrenia. J Psychiatr Res. 2011;45:980\u20138. https:\/\/doi.org\/10.1016\/j.jpsychires.2011.01.006.","journal-title":"J Psychiatr Res"},{"key":"838_CR80","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bpsc.2015.12.001","volume":"1","author":"KH Karlsgodt","year":"2016","unstructured":"Karlsgodt KH. Diffusion imaging of white matter in schizophrenia: progress and future directions. Biol Psychiatry Cogn Neurosci Neuroimaging. 2016;1:209\u201317. https:\/\/doi.org\/10.1016\/j.bpsc.2015.12.001.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"838_CR81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jpsychires.2005.05.005","volume":"41","author":"M Kubicki","year":"2007","unstructured":"Kubicki M, McCarley R, Westin CF, Park HJ, Maier S, Kikinis R, et al. A review of diffusion tensor imaging studies in schizophrenia. J Psychiatr Res. 2007;41:15\u201330. https:\/\/doi.org\/10.1016\/j.jpsychires.2005.05.005.","journal-title":"J Psychiatr Res"},{"key":"838_CR82","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.tins.2011.01.004","volume":"34","author":"KR Tan","year":"2011","unstructured":"Tan KR, Rudolph U, L\u00fcscher C. Hooked on benzodiazepines: GABAA receptor subtypes and addiction. Trends Neurosci. 2011;34:188\u201397. https:\/\/doi.org\/10.1016\/j.tins.2011.01.004.","journal-title":"Trends Neurosci"},{"key":"838_CR83","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/J.1600-0447.1976.TB00065.X","volume":"53","author":"K Fruensgaard","year":"1976","unstructured":"Fruensgaard K, WITHDRAWAL, PSYCHOSIS: A STUDY OF 30 CONSECUTIVE CASES. Acta Psychiatr Scand. 1976;53:105\u201318. https:\/\/doi.org\/10.1111\/J.1600-0447.1976.TB00065.X.","journal-title":"Acta Psychiatr Scand"},{"key":"838_CR84","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.21037\/qims-24-151684","volume":"15","author":"M Yi","year":"2025","unstructured":"Yi M, Wang T, Li X, Jiang Y, Wang Y, Zhang L, et al. White matter microstructural alterations are associated with cognitive decline in benzodiazepine use disorders: a multi-shell diffusion magnetic resonance imaging study. Quant Imaging Med Surg. 2025;15:2076\u201393. https:\/\/doi.org\/10.21037\/qims-24-151684.","journal-title":"Quant Imaging Med Surg"},{"key":"838_CR85","doi-asserted-by":"publisher","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","volume":"16","author":"A Adamu","year":"2024","unstructured":"Adamu A, Li S, Gao F, Xue G. The role of neuroinflammation in neurodegenerative diseases: current Understanding and future therapeutic targets. Front Aging Neurosci. 2024;16:1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"838_CR86","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s002130050038","volume":"148","author":"G Griebel","year":"2000","unstructured":"Griebel G, Belzung C, Perrault G, Sanger DJ. Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology. 2000;148(2):164\u201370. https:\/\/doi.org\/10.1007\/s002130050038.","journal-title":"Psychopharmacology"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00838-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:04:38Z","timestamp":1773241478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00838-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00838-6","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"19 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In this article, the second affiliation for Dr. Marco Feligioni has been added.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the guidelines of the Council of European Communities (European Communities Council Directive of November 24th, 1986, 86\/609\/EEC) and following the approval of the Bioethical Committee of the Italian National Institute of Health (Istituto Superiore di Sanit\u00e0), and the Italian Ministry of Health (n. 234\/2022-PR, 07\/04\/2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"NA.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}